Haverford Financial Services’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-89,375
| Closed | -$7.13M | – | 42 |
|
|
2024
Q1 | $7.13M | Sell |
89,375
-7,861
| -8% | -$600K | 2.05% | 24 |
|
|
2023
Q4 | $7.68M | Buy |
97,236
+283
| +0.3% | +$20.1K | 2.3% | 21 |
|
|
2023
Q3 | $6.77M | Sell |
96,953
-44,235
| -31% | -$3.13M | 2.18% | 24 |
|
|
2023
Q2 | $9.76M | Sell |
141,188
-592
| -0.4% | -$42.1K | 2.91% | 18 |
|
|
2023
Q1 | $10.5M | Sell |
141,780
-4,636
| -3% | -$389K | 3.29% | 13 |
|
|
2022
Q4 | $13.6M | Sell |
146,416
-31,320
| -18% | -$3.02M | 3.76% | 9 |
|
|
2022
Q3 | $17M | Sell |
177,736
-55
| -0% | -$5.44K | 5.19% | 3 |
|
|
2022
Q2 | $16.5M | Sell |
177,791
-16,266
| -8% | -$1.59M | 4.8% | 4 |
|
|
2022
Q1 | $19.6M | Sell |
194,057
-4,737
| -2% | -$498K | 4.84% | 3 |
|
|
2021
Q4 | $20.5M | Sell |
198,794
-5,361
| -3% | -$495K | 4.64% | 5 |
|
|
2021
Q3 | $17.3M | Sell |
204,155
-2,508
| -1% | -$210K | 4.21% | 7 |
|
|
2021
Q2 | $17.2M | Sell |
206,663
-3,396
| -2% | -$278K | 4.21% | 8 |
|
|
2021
Q1 | $15.8M | Sell |
210,059
-897
| -0.4% | -$65.3K | 4.13% | 8 |
|
|
2020
Q4 | $14.4M | Buy |
210,956
+8,774
| +4% | +$571K | 3.93% | 11 |
|
|
2020
Q3 | $11.8M | Buy |
202,182
+956
| +0.5% | +$59.5K | 3.63% | 11 |
|
|
2020
Q2 | $13.1M | Sell |
201,226
-96
| -0% | -$6.04K | 4.4% | 8 |
|
|
2020
Q1 | $11.9M | Buy |
201,322
+13,002
| +7% | +$868K | 4.83% | 5 |
|
|
2019
Q4 | $14M | Sell |
188,320
-1,987
| -1% | -$140K | 4.45% | 6 |
|
|
2019
Q3 | $12M | Buy |
190,307
+14,358
| +8% | +$851K | 4.07% | 8 |
|
|
2019
Q2 | $9.59M | Sell |
175,949
-749
| -0.4% | -$40.3K | 3.33% | 13 |
|
|
2019
Q1 | $9.53M | Buy |
176,698
+26,897
| +18% | +$1.66M | 3.42% | 11 |
|
|
2018
Q4 | $9.81M | Buy |
149,801
+31,671
| +27% | +$2.36M | 4.05% | 9 |
|
|
2018
Q3 | $9.3M | Sell |
118,130
-1,164
| -1% | -$83.2K | 3.3% | 13 |
|
|
2018
Q2 | $7.68M | Sell |
119,294
-15,048
| -11% | -$992K | 2.88% | 16 |
|
|
2018
Q1 | $8.36M | Buy |
134,342
+27,863
| +26% | +$2M | 3.18% | 13 |
|
|
2017
Q4 | $7.72M | Sell |
106,479
-999
| -0.9% | -$72.6K | 2.82% | 16 |
|
|
2017
Q3 | $8.74M | Sell |
107,478
-461
| -0.4% | -$36.5K | 3.42% | 9 |
|
|
2017
Q2 | $8.69M | Sell |
107,939
-3,228
| -3% | -$255K | 3.54% | 12 |
|
|
2017
Q1 | $8.73M | Sell |
111,167
-1,211
| -1% | -$96.7K | 3.59% | 13 |
|
|
2016
Q4 | $8.87M | Sell |
112,378
-506
| -0.4% | -$40.9K | 3.74% | 12 |
|
|
2016
Q3 | $10M | Sell |
112,884
-850
| -0.7% | -$80.2K | 4.32% | 5 |
|
|
2016
Q2 | $10.9M | Sell |
113,734
-1,544
| -1% | -$154K | 4.6% | 3 |
|
|
2016
Q1 | $12M | Sell |
115,278
-2,313
| -2% | -$225K | 5.04% | 1 |
|
|
2015
Q4 | $11.5M | Buy |
117,591
+3,082
| +3% | +$302K | 4.9% | 1 |
|
|
2015
Q3 | $11M | Sell |
114,509
-11,267
| -9% | -$1.18M | 5.1% | 1 |
|
|
2015
Q2 | $13.2M | Sell |
125,776
-9,937
| -7% | -$1.02M | 5.57% | 1 |
|
|
2015
Q1 | $14M | Sell |
135,713
-1,095
| -0.8% | -$111K | 5.68% | 1 |
|
|
2014
Q4 | $13.2M | Sell |
136,808
-1,429
| -1% | -$126K | 5.4% | 1 |
|
|
2014
Q3 | $11M | Buy |
138,237
+1,566
| +1% | +$123K | 4.95% | 2 |
|
|
2014
Q2 | $10.3M | Sell |
136,671
-2,781
| -2% | -$210K | 4.52% | 4 |
|
|
2014
Q1 | $10.4M | Sell |
139,452
-274
| -0.2% | -$19.4K | 4.77% | 3 |
|
|
2013
Q4 | $10M | Buy |
139,726
+7,339
| +6% | +$472K | 4.71% | 3 |
|
|
2013
Q3 | $7.51M | Buy |
132,387
+4,022
| +3% | +$240K | 4.14% | 7 |
|
|
2013
Q2 | $7.34M | Buy |
+128,365
| New | +$7.44M | 4.13% | 6 |
|
Other funds holding CVS
Haverford Financial Services's CVS Position: Q2 2024 in Review
Haverford Financial Services sold out of CVS Health (CVS) in Q2 2024, closing a stake of 89,375 shares — an estimated $7.13M sold.
Haverford Financial Services first reported a position in CVS in Q2 2013 and held it in 44 quarters. The position peaked at $20.5M in Q4 2021. 1,911 funds tracked by Wall St. Rank hold CVS as of Q2 2024.
- Haverford Financial Services reported no remaining CVS Health position as of Q2 2024 after selling out during the quarter.
- Haverford Financial Services sold 89,375 CVS Health shares in Q2 2024, an estimated $7.13M.
- Haverford Financial Services first reported a position in CVS Health in Q2 2013 and held it in 44 quarters.
- Haverford Financial Services's CVS Health position peaked at $20.5M in Q4 2021.
- 1,911 funds tracked by Wall St. Rank held CVS Health as of Q2 2024.
Based on Haverford Financial Services's 13F filing for Q2 2024, filed 12 Aug 2024.